Simultaneous determination of chloroquine, proguanil and their metabolites in human biological fluids by high-performance liquid chromatography

J Pharm Biomed Anal. 1994 Jan;12(1):111-7. doi: 10.1016/0731-7085(94)80018-9.

Abstract

A reversed-phase ion-pair high-performance liquid chromatographic method with ultraviolet detection is described for the simultaneous measurement of chloroquine, proguanil and their major metabolites in human plasma, erythrocytes and urine. After a liquid-solid extraction on a Bond Elut C8 cartridge, the compounds are separated on a C8 Lichrospher 60 RP select B column by isocratic elution; the mobile phase is water-acetonitrile-methanol (78:28:4, v/v/v) with 0.5 M ammonium formate and 0.075 M perchloric acid. The eluent is monitored with an ultraviolet detector at 254 nm. The lower limits of quantification in plasma are near 6.0 ng ml-1 for chloroquine and near 9.0 ng ml-1 for proguanil. No chromatographic interference can be detected from endogenous compounds or from other antimalarial drugs. The method is accurate and precision is good with inter- and intra-assay relative standard deviations lower than 6.8% for plasma samples. N-(2-6 dichlorobenzylidene amino)guanidine is used as an internal standard. The chromatographic procedure takes 35 min and can be used for therapeutic drug monitoring and clinical studies.

MeSH terms

  • Antimalarials / blood
  • Antimalarials / urine
  • Calibration
  • Chloroquine / analysis*
  • Chloroquine / blood
  • Chloroquine / metabolism
  • Chloroquine / urine
  • Chromatography, High Pressure Liquid*
  • Erythrocytes / chemistry*
  • Humans
  • Proguanil / analysis*
  • Proguanil / blood
  • Proguanil / metabolism
  • Proguanil / urine
  • Reproducibility of Results
  • Spectrophotometry, Ultraviolet

Substances

  • Antimalarials
  • Chloroquine
  • Proguanil